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Abstract
Objective To evaluate if heroin and cocaine can be distin-
guished using dual-energy CT.
Materials andmethods Twenty samples of heroin and cocaine
at different concentrations and standardized compression (SC)
were scanned in dual-energy mode on a newest generation
Dual Energy 64-row MDCT scanner. CT number, spectral
graphs, and dual-energy index (DEI) were evaluated. Results
were prospectively tested on six original samples from a body
packer. Wilcoxon’s test was used for statistical evaluation.
Results Values are given as median and range. Under SC, the
CT number of cocaine samples (−29.87 Hounsfield unit (HU)
[−125.85; 16.16 HU]) was higher than the CT number of
heroin samples (−184.37 HU [−199.81; −159.25 HU];
p<0.01). Slope of spectral curves for cocaine was
−2.36 HU/keV [−7.15; −0.67 HU/keV], and for heroin,
1.75 HU/keV [1.28; 2.5 HU/keV] (p<0.01). DEI was
0.0352 [0.0081; 0.0528] for cocaine and significantly higher
than for heroin samples (−0.0127 [−0.0097; −0.0159];
p<0.001).While CT number was inconclusive, all six original
packs were correctly classified after evaluation of the spectral
curve and DEI. In contrast to the CT number, slope of the
spectral curve and DEI were independent of concentration and
compression.
Conclusion The slope of the spectral curve and the DEI from
dual-energy CT data can be used to distinguish heroin and
cocaine in vitro; these results are independent of compression
and concentration in the measured range.
Keywords Body packing . Dual-energy CT . Dual-energy
index .Material differentiation . Illicit drugs
Introduction
Body packers, pushers, and stuffers ingest a variable number
of packs filled with illicit drugs by swallowing (classical body
packers and body stuffers) or inserting them rectally or vagi-
nally (body pushers), e.g., in order to smuggle them across
borders [1, 2]. In the western hemisphere, cocaine and heroin
pose the majority of illicit drugs transported by body packers
[3–5], whereas other drugs play a minor role.
The number of cases of intracorporeal drug smuggling in
Europe and the USA has been rising continually, especially
during recent years [6, 7]. As a result, medical practitioners,
particularly at emergency departments, are increasingly
confronted with diagnostic and therapeutic challenges in the
context of body packing [6–10]. On the diagnostic side,
radiological imaging has played an important part. It can be
crucial to detect and localize incorporated packs both in purely
forensic as well as in mainly medical indications, when
suspected body packers present with symptoms of bowel
obstruction or drug intoxication [8, 11–13]. Modern imaging
techniques allow experienced radiologists to detect packs
incorporated by suspected body packers with a high degree
of certainty; computed tomography (CT) is becoming the first-
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line diagnostic modality with a sensitivity approaching 100 %
[10, 11, 14–18].
Any single pack being smuggled regularly contains a lethal
dose of the narcotic; so, pack rupture or leakage can cause life-
threatening symptoms of intoxication, the so-called body
packer syndrome [4, 6, 7, 19, 20]. Today, no reliable means
exist to distinguish leakage of a transported pack from con-
sumption [21]. This decreases diagnostic confidence in emer-
gency situations, as a body packer carrying cocaine may show
signs of prior heroin abuse and vice versa. Current standard
therapy for both heroin and cocaine body packers showing
symptoms of intoxication is emergency laparotomy to imme-
diately remove all packs, irrespective of the type of drug
transported [6, 8, 22]. Complications of emergency laparoto-
my in body packers are reported to be higher than in laparot-
omies for other reasons, a fact that may be attributed to the
frequent necessity of multiple intestinal incisions if large
numbers of packs are carried [8, 23]. Heroin intoxication,
however, can in some cases be treated conservatively by
administration of the antidote naloxone under intensive care
supervision [12, 20]. It may also be helpful to know which
substance an asymptomatic body packer is carrying to deter-
mine which effects of a potential intoxication need to be
expected and the precautions that need to be taken.
As the body packer may be unable or unwilling to reveal the
content of the carried packs, a method to objectively determine
pack contents without patient cooperation would be helpful.
A few attempts regarding objective differentiation of illicit
drugs can be found in the literature. Wackerle et al. were the
first to publish radiation density measurements of illicit drugs in
1986 [9], suggesting that heroin and cocaine might be distin-
guished according to their Hounsfield units (HU) in CT. This
approach appears questionable because radiation density
should vary with the concentration, chemical structure and
composition of the substance, and the method of pack manu-
facture [11, 24]. Especially the level of compression as a
physical property of the examined material should heavily
influence measured CT numbers [25]. Consequently, CT num-
bers reported for heroin and cocaine in the literature vary
significantly [9, 14, 26–28]. Technical advances and the intro-
duction of dual-energy CT scanners have made it possible to
distinguish different materials. This technology has already
been used to differentiate between various materials like differ-
ent renal calculi [29–33] and is beginning to be applied in
forensic imaging [34]. The use of dual-energy CT to distinguish
heroin and cocaine in vitro has been reported in one experi-
mental study by Leschka et al. [28] on hand-wrapped drug
packets. This study, however, suffers from some major limita-
tions impairing its comparability. Most importantly, it used an
incorrect formula to calculate the dual-energy index (DEI) so
that the dual-energy CT part of the study cannot be correctly
interpreted. Furthermore, regarding attenuation measurements,
the compression of the drug packages was neither known nor
uniform between different packs so that it cannot be deter-
mined, if differences measured are to be attributed to changes
in material composition or differing degrees of compression.
The purpose of our study was to eliminate these limitations
and examine whether material differentiation using dual-
energy CT (DECT) is robust regarding different degrees of
concentration and compression and if it can be used to distin-
guish between the drugs most frequently carried by body
packers in the western hemisphere: heroin and cocaine.
Materials and methods
Experimental samples
All samples were provided and all experiments were moni-
tored by state authorities. In our experiments, we used six
samples of heroin and eight samples of cocaine representing
the vast majority of drugs smuggled by body packers. All of
the 14 samples originated from different actual body packers
and were analyzed by state authorities to contain different
concentrations of between 20 and 38 % heroin and between
21 and 78 % cocaine hydrochloride, respectively.
Experimental setup
To exclude the influence of different mechanical manufacturing
processes on imaging properties of body packs, we developed
an experimental setup to apply a standardized amount of pres-
sure on the samples. Each of the 14 samples was filled into a
polycarbonate high-pressure syringe (CCSB911, Merit Medi-
cal, South Jordan, UT, USA) closed at the front and then
compressed with a force (F) of 1,000 N (see Fig. 1 for further
details of the experimental setup). The compressing force ap-
plied was measured using an electronic precision dynamometer
(PCE-FG 1k, PCE Deutschland GmbH, Meschede, Germany).
Internal diameter (D) of the syringe as provided by the manu-
facturer was 1.94 cm; the internal cross-sectional area (A) was
circular and calculated to be 2.96 cm2 using the formula A=1/
4×π×D2. The resulting pressure (P) applied to the sample was
3,383 kPa or 33.83 bar, calculated using the formula P=F/A.
Original packs
In February 2011, a 19-year-old male, who had swallowed 73
packs filled with illicit drugs, was under medical treatment at
our institution. Six of these packs were provided to us by state
authorities and scanned in their original state (Fig. 2). The
analysis conducted by state authorities revealed that all six
samples contained 77 % cocaine hydrochloride, diluted with
levamisole, and wrapped in aluminum foil and paraffin. All
readers were blinded with regard to pack contents throughout
the radiological part of the experiments.
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Original pack samples
The six original packs were then opened for investigation by
the Bavarian State Criminal Police Office and returned to us to
repeat the measurements under the same standardized com-
pression conditions used for the other samples in the first part
of the experiment.
CT scan parameters
CT scans were obtained using a 64-row MDCT Scanner
(CT750HDDiscovery, GE Healthcare, Waukesha, Milwaukee).
Scan parameters were as follows: tube voltage 80/140 kVp
(dual-energy mode), tube current 600 mA, rotation time 1.0 s,
slice collimation 0.625 mm, and pitch 0.984:1. Images were
reconstructed in a soft tissue kernel to a slice thickness of
1.25 mm.
Image evaluation
Image evaluation was done by two radiologists with 4 (JMG)
and 11 (MS) years of experience in CT evaluation and one
medical student (RMW) in consensus. A circular region of
interest (ROI) of approximately 100 mm2 was placed in the
lumen of each syringe or original pack on axial reconstructions;
inclusion of the syringe or pack wall was carefully avoided.
The scanner’s software for dual-energy evaluation (Gem-
stone Spectral ImagingTM, GE Healthcare, Waukesha, Mil-
waukee) was used to generate a spectral graph from each of
the ten ROIs for each sample. This graph plots CT number in
HU (y-axis) as a function of photon energy ranging from 40 to
140 keV (x-axis). To numerically evaluate characteristics of
the spectral curves, the average slope was calculated as
Δ(HU)/Δ(keV), i.e., Δ(y)/Δ(x). Average slopes were evalu-
ated between 40 and 80 keV because slopes tend to be greater
at lower keV levels so that the greatest differences were
expected at low keV levels. For comparison with CT scanners
of different manufacturers, the dual-energy index (DEI) was
also calculated according to the formula (HU at 80 kVp−HU
at 140 kVp)/(HU at 80 kVp+HU at 140 kVp+2,000) [35].
With the scanner’s software, it is also possible to compute
monochromatic images from the dual-energy data set for any
desired keV level between 40 and 140. The mean CT number
of each ROI was measured in a computed monochromatic 65-
keV image, which we found to be the closest match of the
clinical standard for abdominal CT at 120 kVp tube voltage.
The DEI was calculated post hoc frommonochromatic images
at 45 keV (most closely representing 80 kVp) and 75 keV
(most closely representing 140 kVp).
Statistical analysis
Statistical analysis was performed using Wilcoxon’s test for
independent samples (SPSS 20, IBM Corp., Armonk, NY,
USA). A p value <0.01 was considered statistically significant.
Results
As normal distribution cannot be assumed, values for CT
number and average slope are given as median and range.
Table 1 shows an overview.
Experimental samples
Under standard compression conditions, the CT number of the
cocaine samples (−29.87 HU [−125.85; 16.16 HU]) was
Fig. 2 Original body pack. This figure shows an original body pack from
the body packer case containing 77 % cocaine hydrochloride diluted with
levamisole
Fig. 1 Experimental setup for standardized compression. This figure
shows a photograph of the experimental setup and a corresponding CT
scan. The high-pressure syringe was filled with the drug sample and
placed in the mainly wooden compression apparatus with an electronic
pressure measuring device located between the syringe and the compres-
sion apparatus. To minimize artifacts, no metal parts were in the optical
path during CT scans
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higher than the CT number of the heroin samples
(−184.37 HU [−199.81; −159.25 HU]; p<0.01).
The spectral graphs of all cocaine samples showed a falling
curve with a negative average slope of −2.36 HU/keV [−7.15;
−0.67 HU/keV]. In contrast, all graphs for heroin samples
showed a rising curve with a positive average slope of
1.75 HU/keV [1.28; 2.5 HU/keV], significantly differing from
the slopes of the cocaine samples (p<0.001). Figure 3 displays
spectral graphs. The DEI for heroin samples was −0.0127
[−0.0097; −0.0159] and significantly lower than for cocaine
samples (0.0352 [0.0081; 0.0528]; p<0.001).
With these results, the hypothesis was proposed that aver-
age slopes of spectral curves of heroin samples are positive,
while they are negative for cocaine samples. The opposite
should hold true for the DEI.
We had the opportunity to test this hypothesis on six
samples from a body packer, who presented at our hospital
shortly after completion of the described experiments.
Original packs
Median CT number of the six original packs was 65.71 HU
[46.57; 80.8 HU]. In their original state, the CT number of the
packs differed significantly from both cocaine and heroin
samples measured in the first part of the experiment
(p<0.01, respectively).
Spectral graphs for all six samples in their original state
showed a falling curve with a median slope of −5.27 HU/
keV [−5.83; −4.75 HU/keV]. This value differed signifi-
cantly from slopes of the heroin samples (p<0.01), but not
from slopes of the cocaine samples (p=0.14) from the first
part of the experiment. Accordingly, the median DEI was
found to be 0.044 [0.042; 0.053], higher than for heroin
(p<0.01) but not significantly different from cocaine sam-
ples (p=0.28).
Original pack samples
After standardized compression at 33.83 bar as described
above, the CT number of the six samples was −64.14 HU
[−85.29; −49.14 HU], significantly different from measure-
ments in their original state (p<0.01). At standardized com-
pression, no significant difference of the CT number was
observed when compared to the cocaine samples (p=0.14).
However, when compared to the heroin samples from the first
part of the experiment, the difference in CT number was
statistically significant (p<0.01).
Spectral graphs for all six samples showed a falling curve
with an average slope of −5.59 HU/keV [−5.77; −2.50 HU/
keV] and a DEI of 0.035 [0.034; 0.036]. Again, when com-
pared to the cocaine samples from the first part of the exper-
iment, no significant difference was observed for the average
Table 1 CT number, average slope of the spectral curve, and dual-energy index
Type of drug CT number at 65 keV [HU] Average slope [HU/keV] Dual-energy index
Heroin SC −184.37 [−159.25; −199.81] 1.75 [1.28; 2.5] −0.013 [−0.001; −0.016];
Cocaine SC −29.87 [−125.85; 16.16] −2.36 [−7.15; −0.67] 0.035 [0.008; 0.053]
Body packs original state 65.71 [46.57; 80.80] −5.27 [−5.83; −4.75] 0.044 [0.042; 0.053]
Body packs SC −64.14 [−85.29; −49.14] −5.59 [−5.77; −2.5] 0.035 [0.034; 0.036]
All values are given as median and range
HU Hounsfield units SC standardized compression
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a
Fig. 3 Spectral curves of heroin and cocaine. This figure shows repre-
sentative spectral graphs of two heroin and one cocaine samples from the
first part of the experiment as well as graphs of an original pack from the
body packer case both in its original state and after standardized
compression. Other curves were similar and are not displayed for better
readability. Note the higher density of the curve for the original pack
which results in an upward displacement of the curve on the plot without
changing its slope
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slope and DEI (p=0.24 and 0.75, respectively); while in
comparison to the heroin samples, the difference of the aver-
age slope and DEI was statistically significant (both p<0.01).
The distribution of average slopes and DEI of all samples is
displayed in Fig. 4.
According to our proposed hypothesis, we concluded that
the packs should contain cocaine rather than heroin. This
conclusion was confirmed by the chemical analyses of the
drug samples.
Discussion
Differentiation of drugs using their CT number
Existing studies report CT numbers between 40 and −520 HU
for heroin and between 247 and −219 HU for cocaine [9, 14,
26–28]. CT numbers observed for the original packs and
under standardized compression conditions were in the range
of values reported for both substances, though this range is
extremely wide (Fig. 5). Similar to previous reports [9, 11,
28], cocaine samples showed higher CT numbers than heroin
samples in our experiments.
Influence of compression
The cocaine body packs from the described case in their
original form yielded a CT number significantly (on average
around 130 HU) higher than the respective samples under
standardized compression. Since the chemical properties of
the samples from our case remained the same throughout our
experiments, this difference in CT number can only be attrib-
uted to the degree of compression, suggesting amanufacturing
process with a compression well beyond 33.38 bar for the
original packs. This result is not surprising, as a higher phys-
ical density, i.e., mass per volume, for the same chemical
substance can be expected to result in a higher CT number
[25]. Thus, even for the same substance, different manufactur-
ing processes using different degrees of compression lead to
different physical densities of the fabricated packs which will
consequently show different CT numbers.
Influence of concentration
In our study, CT numbers under standardized compression
conditions ranged from −125.85 to 16.16 HU for cocaine and
from −199.81 to −159.25 HU for heroin samples,
encompassing a range of roughly 140 HU for cocaine and
40 HU for heroin. Since the influence of different mechanical
manufacturing processes was excluded by applying a stan-
dardized amount of pressure on all samples, this difference in
CT number can only be attributed to varying chemical prop-
erties like concentration of a substance and the diluents used.
This study, to our knowledge, presents the first report of
using a standardized compression to exclude the influence of
the manufacturing process of illicit drug packages on CT
number measurements. When this is not done, as in most
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Fig. 4 a Average slopes of spectral curves for heroin and cocaine. This
figure shows the average slope of spectral curves of heroin and cocaine
from all samples used in our experiments in comparison. Note the
grouping of values for cocaine below and for heroin above zero
representing rising spectral curves for heroin and dropping curves for
cocaine. b Dual-energy index for heroin and cocaine. This figure shows
the dual-energy index of heroin and cocaine from all samples used in our
experiments in comparison. Note the grouping of values comparable to
the average slope, but for the dual-energy index of cocaine above and for
heroin below zero
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existing studies, it is impossible to distinguish the influence of
compression from the influence of chemical composition.
Thus, our study supports the thesis that the CT number of
drug samples is greatly dependent on the manufacturing pro-
cess [11, 26, 28] so that a reliable distinction of heroin and
cocaine using the CT number is not possible when concentra-
tion and compression are unknown.When the influence of the
respective other variable was excluded, changes in compres-
sion and chemical properties of heroin and cocaine samples
resulted in major changes of their CT number in our experi-
ments. A differentiation of narcotics using their CT number
may be possible only if the concentration and degree of
compression of the different samples compared is identical
or at least known to the observer. Since this information will
regularly be impossible to obtain under clinical conditions, the
CT number is impractical to distinguish between heroin and
cocaine of unknown manufacturing process.
Differentiation of illicit drugs using dual-energy CT
The differentiation of illegal drugs using the average slope of
their spectral curve or the correct DEI has to our knowledge
not been reported yet. As mentioned before, Leschka et al.
[28] unfortunately used an incorrect formula for calculation of
the DEI, so that their results cannot be compared to ours or the
existing literature. Our experiments suggest that a differentia-
tion of heroin and cocaine is possible by evaluating the spec-
tral curve from a dual-energy CT as well as by using the DEI
of the substance examined. In our experiments, we found a
negative average slope and positive DEI for cocaine, and a
positive average slope and negative DEI for heroin. In contrast
to the CT number, both average slope and DEI were indepen-
dent of concentration and compression of the drug samples in
the range examined.
Based on these findings, the hypothesis can be formulated
that cocaine should show a higher average slope and lower
DEI than heroin with a cutoff value close to zero for both
parameters.
The DEI delivered statistically comparable results to the
average slope of the spectral curve and seems to be equally
well suited to differentiate heroin and cocaine.
Limitations
One limitation of our study is the relatively small number of
samples. This is owed to the sensitive nature of the examined
substances and well in the range of existing publications. We
did not evaluate the influence of different diluents, as the
number of substances used to dilute drugs was too large to
be evaluated in our relatively small sample. It can be expected
that the influence of diluents on imaging characteristics of
drugs increases with decreasing drug concentration. However,
since body packers usually carry drugs at relatively high
concentrations to increase market value of the load, this influ-
ence is likely to be lower than in concentrations adapted for
consumption. Furthermore, the independency of the DEI and
slope of the spectral curve from concentration and compres-
sion of the drug samples in the range examined shows that our
proposed method of differentiation is robust.
Our results are based on in vitro examinations. Therefore,
the method needs to be further validated in animal models
* HU = Hounsfield Units
a: Wackerle et al., RoFo 1986
b: Yang et al., South Med J 2009
c: Maurer et al., Eur Radiol 2011
d: Pache et al., RoFo 2012
f: This study
e: Leschka et al., JOFRI 2013 
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Fig. 5 HU values reported for heroin and cocaine. This figure shows the
HU values for heroin and cocaine reported in the literature until today,
irrespective of concentration and degree of compression. If more than two
values were reported, the highest and the lowest reported CT numbers are
displayed in the diagram. If multiple tube voltages were used, only the
values for 120 kVp are given. Note the large overlap between values for
heroin and cocaine demonstrating the impracticability of a distinction
between both substances using their CT number
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and/or in vivo before being considered for routine clinical
application.
Conclusion
Results of our study confirm that the CT number is not a
suitable indicator for the type of drug being transported by a
body packer. It varies greatly with different concentration and
compression of a substance, parameters which are unlikely to
be obtainable under clinical conditions.
A distinction of heroin and cocaine seems possible using
the average slope of the spectral curve and the DEI from dual-
energy spectral imaging CT data. In vitro, these parameters
deliver significant differences between both substances, inde-
pendent of concentration and compression of the samples. If
confirmed, these results might alter clinical handling of symp-
tomatic body packers.
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